← Leaderboards
Helen M Blau
Stanford University
$36,149,136
Attributed
$37,856,757
Total exposure
21
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,856,757 · 21
By mechanism
R01$32,640,343 · 13
R37$2,294,881 · 1
T32$1,123,071 · 2
RC1$947,869 · 1
R21$800,593 · 2
R13$50,000 · 2
Top collaborators
- Anshul Kundaje3 shared
- Sarah C Heilshorn2 shared
- Juan Gabriel Santiago2 shared
Most similar at Stanford University
Same institution · by research overlap
- Scott L Delp$38,724,527
- Samuel Strober$36,157,957
- Juan Gabriel Santiago$473,935
- Samuel Stober$895,356
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMuscleTissuesAgingBaseProteinsTechnologyIn VivoStem CellsMuscle Satellite CellSignal TransductionPhenotypeTransplantationIn VitroCell PhysiologyRegenerativeRegulationHydrogelsLaboratoriesMolecularLeadInsightRepairedResponse
Grant awards (99)
Control of Muscle Stem Cells to Enhance Regeneration$507,667
R01 · FY2025 · AG · contact PI
Control of Muscle Stem Cells to Enhance Regeneration$514,472
R01 · FY2024 · AG · contact PI
Dynamic Biomaterial Design to Probe the Cellular Response to Fibrotic Stiffening$393,500
R01 · FY2024 · HL · contact PI
Control of Muscle Stem Cells to Enhance Regeneration$517,888
R01 · FY2023 · AG · contact PI
Regulation of eicosanoid signaling lipids to improve skeletal muscle function and increase healthspan during aging$402,230
R01 · FY2023 · AG · contact PI
Dynamic Biomaterial Design to Probe the Cellular Response to Fibrotic Stiffening$393,500
R01 · FY2023 · HL · contact PI
Control of Muscle Stem Cells to Enhance Regeneration$485,262
R01 · FY2022 · AG · contact PI
Regulation of eicosanoid signaling lipids to improve skeletal muscle function and increase healthspan during aging$401,998
R01 · FY2022 · AG · contact PI
Dynamic Biomaterial Design to Probe the Cellular Response to Fibrotic Stiffening$393,500
R01 · FY2022 · HL · contact PI
Improvement and standardization of a bioinformatic software suite for multiplexed imaging$218,717
R01 · FY2022 · AG · contact PI
Regulation of eicosanoid signaling lipids to improve skeletal muscle function and increase healthspan during aging$597,186
R01 · FY2021 · AG · contact PI
Regulation of eicosanoid signaling lipids to improve skeletal muscle function and increase healthspan during aging$401,772
R01 · FY2021 · AG · contact PI
Dynamic Biomaterial Design to Probe the Cellular Response to Fibrotic Stiffening$393,563
R01 · FY2021 · HL · contact PI
Regulation of eicosanoid signaling lipids to improve skeletal muscle function and increase healthspan during aging$401,555
R01 · FY2020 · AG · contact PI
Learning Regulatory Drivers of Chromatin and Expression Dynamics during Nuclear Reprogramming$703,311
R01 · FY2019 · HG
Regulation of Muscle Stem Cell Fate$330,405
R01 · FY2019 · AG · contact PI
Learning Regulatory Drivers of Chromatin and Expression Dynamics during Nuclear Reprogramming$702,694
R01 · FY2018 · HG
Regulation of Muscle Stem Cell Fate$330,317
R01 · FY2018 · AG · contact PI
Regulation of Muscle Stem Cell Fate$66,820
R01 · FY2018 · AG · contact PI
Learning Regulatory Drivers of Chromatin and Expression Dynamics during Nuclear Reprogramming$694,416
R01 · FY2017 · HG
Regulation of Muscle Stem Cell Fate$330,534
R01 · FY2017 · AG · contact PI
Mass Cytometry Analysis of Signaling Dysfunction in Duchenne Muscular Dystrophy$323,715
R01 · FY2017 · NS · contact PI
Telomere extension using nucleoside-modified mRNA and exosomes as a novel therape$867,325
R01 · FY2016 · AR · contact PI
Regulation of Muscle Stem Cell Fate$331,285
R01 · FY2016 · AG · contact PI
Mass Cytometry Analysis of Signaling Dysfunction in Duchenne Muscular Dystrophy$323,541
R01 · FY2016 · NS · contact PI
Telomere extension using nucleoside-modified mRNA and exosomes as a novel therape$869,065
R01 · FY2015 · AR · contact PI
Regulation of Muscle Stem Cell Fate$331,141
R01 · FY2015 · AG · contact PI
Mass Cytometry Analysis of Signaling Dysfunction in Duchenne Muscular Dystrophy$323,378
R01 · FY2015 · NS · contact PI
Telomere extension using nucleoside-modified mRNA and exosomes as a novel therape$865,952
R01 · FY2014 · AR · contact PI
Activators of Muscle Genes$481,163
R01 · FY2014 · AG · contact PI
Mass Cytometry Analysis of Signaling Dysfunction in Duchenne Muscular Dystrophy$322,909
R01 · FY2014 · NS · contact PI
Safe, Rapid Telomere Extension to Prevent and Treat Hypertension$197,137
R21 · FY2014 · AG · contact PI
Telomere extension using nucleoside-modified mRNA and exosomes as a novel therape$836,447
R01 · FY2013 · AR · contact PI
Regulation of Hematopoietic Stem Cell Fate in Bioengineered Niches$509,941
R01 · FY2013 · HL · contact PI
Activators of Muscle Genes$455,355
R01 · FY2013 · AG · contact PI
Regulation of Muscle Stem Cell Fate$271,057
R01 · FY2013 · AG · contact PI
Safe, Rapid Telomere Extension to Prevent and Treat Hypertension$236,503
R21 · FY2013 · AG · contact PI
Telomere extension using nucleoside-modified mRNA and exosomes as a novel therape$860,511
R01 · FY2012 · AR · contact PI
Regulation of Hematopoietic Stem Cell Fate in Bioengineered Niches$538,566
R01 · FY2012 · HL · contact PI
Activators of Muscle Genes$462,726
R01 · FY2012 · AG · contact PI
Regulation of Muscle Stem Cell Fate$286,638
R01 · FY2012 · AG · contact PI
3D Bioengineering Strategies to Mimic Human Skeletal Muscle Progenitor Cell Niche$165,629
R21 · FY2012 · AR
Regulation of Hematopoietic Stem Cell Fate in Bioengineered Niches$541,563
R01 · FY2011 · HL · contact PI
Activators of Muscle Genes$453,961
R01 · FY2011 · AG · contact PI
Regulation of Muscle Stem Cell Fate$286,434
R01 · FY2011 · AG · contact PI
3D Bioengineering Strategies to Mimic Human Skeletal Muscle Progenitor Cell Niche$201,324
R21 · FY2011 · AR
2011 Myogenesis Gordon Research Conference$35,000
R13 · FY2011 · AG · contact PI
Regulation of Hematopoietic Stem Cell Fate in Bioengineered Niches$544,599
R01 · FY2010 · HL · contact PI
Remote-control mouse-implantable micropumps for establishment of regenerative cap$458,340
RC1 · FY2010 · AR
Activators of Muscle Genes$447,086
R01 · FY2010 · AG · contact PI
Regulation of Muscle Stem Cell Fate$289,121
R01 · FY2010 · AG · contact PI
Regulation of Hematopoietic Stem Cell Fate in Bioengineered Niches$557,186
R01 · FY2009 · HL · contact PI
Remote-control mouse-implantable micropumps for establishment of regenerative cap$489,529
RC1 · FY2009 · AR
Activators of Muscle Genes$474,791
R01 · FY2009 · AG · contact PI
Regulation of Muscle Stem Cell Fate$284,062
R01 · FY2009 · AG · contact PI
Activators of Muscle Genes$462,746
R01 · FY2008 · AG · contact PI
Regulator of Adult Stem Cell Fate$300,216
R01 · FY2008 · AG · contact PI
Activators of Muscle Genes$460,262
R01 · FY2007 · AG · contact PI
Regulation of Muscle Development$327,959
R01 · FY2007 · HD · contact PI
Regulator of Adult Stem Cell Fate$306,230
R01 · FY2007 · AG · contact PI
Regulator of Adult Stem Cell Fate$90,225
R01 · FY2007 · AG · contact PI
Activators of Muscle Genes$462,082
R01 · FY2006 · AG · contact PI
Stem Cells for Brain and Brawn$367,693
R01 · FY2006 · AG · contact PI
Regulation of Muscle Development$337,654
R01 · FY2006 · HD · contact PI
Regulator of Adult Stem Cell Fate$315,265
R01 · FY2006 · AG · contact PI
Activators of Muscle Genes$50,000
R01 · FY2006 · AG · contact PI
Activators of Muscle Genes$470,863
R01 · FY2005 · AG
Stem Cells for Brain and Brawn$376,401
R01 · FY2005 · AG
Regulation of Muscle Development$345,681
R01 · FY2005 · HD
Regulator of Adult Stem Cell Fate$322,742
R01 · FY2005 · AG
ACTIVATORS OF HUMAN MUSCLE GENES$474,738
R37 · FY2004 · AG
Stem Cells for Brain and Brawn$376,266
R01 · FY2004 · AG
Regulation of Muscle Development$343,094
R01 · FY2004 · HD
Regulator of Adult Stem Cell Fate$322,637
R01 · FY2004 · AG
13th International Society of Differentiation Conference$15,000
R13 · FY2004 · HD
ACTIVATORS OF HUMAN MUSCLE GENES$459,572
R37 · FY2003 · AG
Stem Cells for Brain and Brawn$376,136
R01 · FY2003 · AG
DELIVERY AND REGULATION OF ANGIOGENIC GENES$353,885
R01 · FY2003 · HL
Regulation of Muscle Development$340,698
R01 · FY2003 · HD
ACTIVATORS OF HUMAN MUSCLE GENES$449,922
R37 · FY2002 · AG
Stem Cells for Brain and Brawn$376,011
R01 · FY2002 · AG
DELIVERY AND REGULATION OF ANGIOGENIC GENES$353,828
R01 · FY2002 · HL
REGULATION OF MUSCLE DEVELOPMENT$315,369
R01 · FY2002 · HD
PREDOCTORAL PHARMACOLOGY TRAINING PROGRAM$208,272
T32 · FY2002 · GM
MOLECULAR PHARMACOLOGY OF DISEASES OF AGING$147,465
T32 · FY2002 · AG
ACTIVATORS OF HUMAN MUSCLE GENES$438,051
R37 · FY2001 · AG
DELIVERY AND REGULATION OF ANGIOGENIC GENES$392,871
R01 · FY2001 · HL
GENE THERAPY FOR CANCER$348,765
R01 · FY2001 · CA
REGULATION OF MUSCLE DEVELOPMENT$306,183
R01 · FY2001 · HD
PREDOCTORAL PHARMACOLOGY TRAINING PROGRAM$197,052
T32 · FY2001 · GM
MOLECULAR PHARMACOLOGY OF DISEASES OF AGING$195,946
T32 · FY2001 · AG
ACTIVATORS OF HUMAN MUSCLE GENES$417,598
R37 · FY2000 · AG
DELIVERY AND REGULATION OF ANGIOGENIC GENES$380,516
R01 · FY2000 · HL
GENE THERAPY FOR CANCER$339,977
R01 · FY2000 · CA
REGULATION OF MUSCLE DEVELOPMENT$297,263
R01 · FY2000 · HD
PREDOCTORAL PHARMACOLOGY TRAINING PROGRAM$187,721
T32 · FY2000 · GM
MOLECULAR PHARMACOLOGY OF DISEASES OF AGING$186,615
T32 · FY2000 · AG
REGULATION OF MUSCLE DEVELOPMENT$100,000
R01 · FY2000 · HD
ACTIVATORS OF HUMAN MUSCLE GENES$55,000
R37 · FY2000 · AG